TAS 103;6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one;TAS-103 HC1;TA103(bms-247615);TAS-103 base;BMS-247615;TAS-103(salt);CS-1287
TAS-103 is a dual inhibitor of DNA topoisomerase I/II and is used in cancer research; it exhibits potent cytotoxicity against various cancer cell lines including CCRF-CEM (IC50 = 5 nM), Lewis lung carcinoma (LLC), and HeLa cells (IC50 = 40 nM); it suppresses tumor growth in vivo in mice bearing Lewis lung carcinoma without significant body weight loss; liposomal formulation of TAS-103 shows enhanced antitumor activity compared to the free form.